Fairmount Funds Management LLC Discloses Investment at Korsana Biosciences with 19.99% Stake
Fairmount Funds Management LLC disclosed a 19.99% stake in Korsana Biosciences, Inc. common stock. The firm filed a Schedule 13D on September 11, 2026, following Korsana’s September 8, 2026 merger and related financing steps. The position gives Fairmount voting and dispositive power over more than…
Fairmount Funds Management LLC disclosed a 19.99% stake in Korsana Biosciences, Inc. common stock. The firm filed a Schedule 13D on September 11, 2026, following Korsana’s September 8, 2026 merger and related financing steps. The position gives Fairmount voting and dispositive power over more than…